FI945014A0 - Biohajoava silmän kovakalvon tappi - Google Patents

Biohajoava silmän kovakalvon tappi

Info

Publication number
FI945014A0
FI945014A0 FI945014A FI945014A FI945014A0 FI 945014 A0 FI945014 A0 FI 945014A0 FI 945014 A FI945014 A FI 945014A FI 945014 A FI945014 A FI 945014A FI 945014 A0 FI945014 A0 FI 945014A0
Authority
FI
Finland
Prior art keywords
drug
sclera
surgical operation
vitreous body
plug
Prior art date
Application number
FI945014A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI945014A (fi
Inventor
Yuichiro Ogura
Yoshito Ikada
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of FI945014A publication Critical patent/FI945014A/fi
Publication of FI945014A0 publication Critical patent/FI945014A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI945014A 1993-02-26 1994-10-25 Biohajoava silmän kovakalvon tappi FI945014A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6281493 1993-02-26
JP6945793 1993-03-04
PCT/JP1994/000273 WO1994018921A1 (fr) 1993-02-26 1994-02-23 Bouchon de sclerotique biodegradable

Publications (2)

Publication Number Publication Date
FI945014A FI945014A (fi) 1994-10-25
FI945014A0 true FI945014A0 (fi) 1994-10-25

Family

ID=26403867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945014A FI945014A0 (fi) 1993-02-26 1994-10-25 Biohajoava silmän kovakalvon tappi

Country Status (12)

Country Link
EP (1) EP0654256B1 (no)
KR (1) KR100313268B1 (no)
AT (1) ATE195065T1 (no)
CA (1) CA2118515A1 (no)
DE (1) DE69425411T2 (no)
DK (1) DK0654256T3 (no)
ES (1) ES2150487T3 (no)
FI (1) FI945014A0 (no)
GR (1) GR3034526T3 (no)
NO (1) NO303665B1 (no)
PT (1) PT654256E (no)
WO (1) WO1994018921A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001156A1 (fr) * 1997-07-02 1999-01-14 Santen Pharmaceutical Co., Ltd. Bouchons scleraux d'acide polylactique
US6991650B2 (en) 1997-10-08 2006-01-31 Refocus Ocular, Inc. Scleral expansion device having duck bill
US7008396B1 (en) 1999-09-03 2006-03-07 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US6375642B1 (en) * 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
EP1637126B1 (en) * 2000-07-05 2016-12-14 Allergan, Inc. Methods for treating inflammation of the eye
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
DK1339438T3 (da) 2000-11-29 2006-02-13 Allergan Inc Forebyggelse af transplantatafvisning i ojet
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20040137059A1 (en) * 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
JP5006651B2 (ja) 2003-12-05 2012-08-22 ブリストル−マイヤーズ スクウィブ カンパニー ２型血管内皮増殖因子受容体の阻害剤
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
CA2658158C (en) 2006-07-11 2014-10-21 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
EP2727936B1 (en) 2006-11-22 2016-09-07 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
WO2009102421A2 (en) 2008-02-14 2009-08-20 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind egfr
EP2291399B1 (en) 2008-05-22 2014-06-25 Bristol-Myers Squibb Company Multivalent fibronectin based scaffold domain proteins
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
EP2576615B1 (en) 2010-05-26 2016-03-30 Bristol-Myers Squibb Company Fibronectin based scaffold proteins having improved stability
KR101750651B1 (ko) * 2016-01-28 2017-06-23 동국대학교 산학협력단 약물 잔류 방지능 및 재충전 기능을 갖는 안구 내 약물 주입 장치
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
US10512534B2 (en) 2016-10-03 2019-12-24 California Institute Of Technology Radioluminescent phototherapy eye device
US11400307B2 (en) 2018-01-31 2022-08-02 California Institute Of Technology Controllable ocular phototherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4634418A (en) * 1984-04-06 1987-01-06 Binder Perry S Hydrogel seton
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
JPH04364857A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道せき止め用ロッド

Also Published As

Publication number Publication date
EP0654256B1 (en) 2000-08-02
DE69425411T2 (de) 2001-02-08
DK0654256T3 (da) 2000-12-18
NO303665B1 (no) 1998-08-17
FI945014A (fi) 1994-10-25
ES2150487T3 (es) 2000-12-01
DE69425411D1 (de) 2000-09-07
KR100313268B1 (ko) 2002-11-22
EP0654256A4 (en) 1995-01-04
GR3034526T3 (en) 2000-12-29
KR950701209A (ko) 1995-03-23
NO944060D0 (no) 1994-10-25
NO944060L (no) 1994-10-25
ATE195065T1 (de) 2000-08-15
CA2118515A1 (en) 1994-02-23
WO1994018921A1 (fr) 1994-09-01
PT654256E (pt) 2000-12-29
EP0654256A1 (en) 1995-05-24

Similar Documents

Publication Publication Date Title
FI945014A0 (fi) Biohajoava silmän kovakalvon tappi
Masket Postoperative complications of capsulorhexis
CA1190001A (en) Posterior chamber lens
US5336175A (en) Method for the treatment of retinal detachments
Olivius et al. Intraocular pressure after cataract surgery with Healon®
ECKARDT A new temporary keratoprosthesis for pars plana vitrectomy
EA199700286A1 (ru) Соединение для офтальмологической хирургии и способ ее осуществления
US4177526A (en) Securing device for an intraocular lens
DK0403360T3 (da) Anvendelse af phenylethanolaminer til fremstilling af et lægemiddel mod øjenlidelser
SU1732965A1 (ru) Искусственный хрусталик глаза
Bowman et al. Noninvasive repositioning of a posterior chamber intraocular lens following pupillary capture
Nishi Extracapsular cataract extraction with keyhole capsulorhexis and lens epithelial cell removal
Lim et al. Surgical management for persistent pupillary membrane with vitreous scissors.
CA2396130A1 (en) Preparation of irrigating solution for ocular surgery
SU1715345A1 (ru) Способ кератопластики
RU2211687C2 (ru) Способ лечения отслойки сетчатки
SU1138155A1 (ru) Способ кератопротезировани
Stark et al. Management of retropseudophakos membranes
SU1512597A1 (ru) Способ удалени вывихнутого хрусталика
SU583801A1 (ru) Способ имплантации искусственного хрусталика
RU2245122C2 (ru) Способ экстракции твердых катаракт
Scheie et al. Choice of a Miotic Agent Following Retrobulbar Anesthesia
Fanta RE: TINA AND VITREOUS
RU2168968C2 (ru) Способ репозиции ущемленной радужки из раны роговицы и склеры в раннем послеоперационном периоде
LG THE NEWER TECHNIQUES IN RETINAL DETACHMENT SURGERY. INDICATIONS FOR THE NEWER METHOD.